genomics startup

‘Highly Selective’ Illumina Accelerator Picks Dallas-Based Doloromics for its Second Funding Cycle

by | Feb 16, 2021
Doloromics, a local therapeutics discovery startup that uses technology to find better ways to treat chronic pain, is one of nine companies selected.
MORE